K. Okuma

AS2553627, a novel JAK inhibitor, prevents chronic rejection in rat cardiac allografts

J. Hirose, M. Inami, Koji Nakamura, 2017, European journal of pharmacology.

Dynamics of Type I and Type II Interferon Signature Determines Responsiveness to Anti-TNF Therapy in Rheumatoid Arthritis

K. Ohmura, Hiromu Ito, M. Hashimoto, 2022, Frontiers in Immunology.

A novel JAK inhibitor, peficitinib, demonstrates potent efficacy in a rat adjuvant-induced arthritis model.

Takayuki Inoue, M. Inami, M. Kuno, 2017, Journal of pharmacological sciences.

Metabolomic approach to the exploration of biomarkers associated with disease activity in rheumatoid arthritis

M. Hashimoto, Ken-ichi Suzumura, I. Aramori, 2019, PloS one.

THU0101 ASP015K: A Novel Jak Inhibitor Demonstrated Potent Efficacy in Adjuvant-Induced Arthritis Model in Rats

N. Seki, M. Inami, M. Ito, 2013 .